Consumer demand for CBD products has soared during lockdown, according to the Association for the Cannabinoid Industry (ACI), which estimates the sector will generate £690 million in annual sales this year, above a previous forecast of £526 million.
The FSA’s recent change to its CBD Novel Foods deadline will lead to a lot of hasty half-hearted applications from companies unaware of how much more difficult the process is about to become, an expert has warned.
Folium Biosciences has become another US-based firm to submit a Novel Foods application to the UK for its cannabidiol (CBD)-based oil in response to the 31 March deadline set by the country’s food authority.
Treehouse Biotech has submitted a Novel Foods application to UK authorities for its Cannabidiol (CBD)-based ingredients in a move that signals the US firm’s intent to capture a slice of the UK’s burgeoning CBD market.
Many UK CBD brands have been misled on how to prepare for the looming novel foods deadline meaning there is less than one month for some to pull together potentially impossible amounts of data, an industry expert has warned.
With the UK deadline for Novel Food applications for CBD products approaching on March 31, industry body the Association for the Cannabinoid Industry (ACI) has announced a partnership with Trading Standards to ensure a smooth transition.
The UK FSA’s requirement for all CBD products to have Novel Foods validation is a “positive direction for an emerging industry” and will “undoubtedly reduce the number of products and brands on the market” says Vitality CBD as it awaits feedback on its...
Researchers in Australia say they have been able to significantly increase the short-term bioavailability of cannabidiol (CBD) in the blood and brain thanks to a new encapsulation technique, and the combined delivery with a ‘absorption enhancer’ - Deoxycholic...